RESPEKT 75 mg/1 tableta film tableta Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

respekt 75 mg/1 tableta film tableta

hemofarm proizvodnja farmaceutskih proizvoda d.o.o. banja luka - klopidogrel - film tableta - 75 mg/1 tableta - 1 film tableta sadrži: 75 mg klopidogrel (u obliku klopidogrelbisulfata)

Camzyos Europska Unija - hrvatski - EMA (European Medicines Agency)

camzyos

bristol-myers squibb pharma eeig - mavacamten - cardiomyopathy, hypertrophic - ostali srčani pripravci - treatment of symptomatic obstructive hypertrophic cardiomyopathy.

Farcet 75 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

farcet 75 mg filmom obložene tablete

adamed sp. z o.o., pienków 149, czosnów, poljska - clopidogrelum - filmom obložena tableta - 75 mg - urbroj: jedna filmom obložena tableta sadrži 75 mg klopidogrela u obliku klopidogrelhidrogensulfata

Pigrel 75 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

pigrel 75 mg filmom obložene tablete

jadran galenski laboratorij d.d., svilno 20, rijeka, hrvatska - klopidogrelhidrogensulfat - filmom obložena tableta - 75 mg - urbroj: 1 filmom obložena tableta sadrži 75 mg klopidogrela u obliku klopidogrel hidrogensulfata

Clopidogrel Acino Europska Unija - hrvatski - EMA (European Medicines Agency)

clopidogrel acino

acino ag - klopidogrel - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - antitrombotska sredstva - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , , , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease, non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa), st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy, patients suffering from acute coronary syndrome. , ,.